 | • レポートコード：QYR2104Z2520 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ムコ多糖症遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、ICV、脳内、大槽内）、用途別市場規模（ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症III型A型、ムコ多糖症型III型B型）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ムコ多糖症遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・ムコ多糖症遺伝子治療の種類別市場規模（静脈内、ICV、脳内、大槽内） ・ムコ多糖症遺伝子治療の用途別市場規模（ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症III型A型、ムコ多糖症型III型B型） ・ムコ多糖症遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・ムコ多糖症遺伝子治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ムコ多糖症遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ムコ多糖症遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ムコ多糖症遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sangamo Therapeutics、Swedish Orphan Biovitrum、uniQure） ・結論 |
Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All of the mucopolysaccharidoses are rare, autosomal recessive, except for mucopolysaccharidosis III, as it is X-linked.
Over the past few years, gene therapy has emerged as one of the most exciting approaches for the treatment of mucopolysaccharidosis. One of the promising therapy is replacement gene therapy, which replaces faulty genes with normal ones in the body. It is considered to be a potential cure to mucopolysaccharidoses and a promising option in the long run.
Market Analysis and Insights: Global Gene Therapy for Mucopolysaccharidosis Market
The global Gene Therapy for Mucopolysaccharidosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy for Mucopolysaccharidosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy for Mucopolysaccharidosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy for Mucopolysaccharidosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy for Mucopolysaccharidosis market.
Global Gene Therapy for Mucopolysaccharidosis Scope and Market Size
Gene Therapy for Mucopolysaccharidosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Mucopolysaccharidosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intravenous
ICV
Intracerebral
Intracisternal
Segment by Application
Mucopolysaccharidosis I
Mucopolysaccharidosis II
Mucopolysaccharidosis III A
Mucopolysaccharidosis III B
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sangamo Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 ICV
1.2.4 Intracerebral
1.2.5 Intracisternal
1.3 Market by Application
1.3.1 Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Mucopolysaccharidosis I
1.3.3 Mucopolysaccharidosis II
1.3.4 Mucopolysaccharidosis III A
1.3.5 Mucopolysaccharidosis III B
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Mucopolysaccharidosis Market Perspective (2016-2027)
2.2 Gene Therapy for Mucopolysaccharidosis Growth Trends by Regions
2.2.1 Gene Therapy for Mucopolysaccharidosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy for Mucopolysaccharidosis Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy for Mucopolysaccharidosis Industry Dynamic
2.3.1 Gene Therapy for Mucopolysaccharidosis Market Trends
2.3.2 Gene Therapy for Mucopolysaccharidosis Market Drivers
2.3.3 Gene Therapy for Mucopolysaccharidosis Market Challenges
2.3.4 Gene Therapy for Mucopolysaccharidosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue
3.1.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy for Mucopolysaccharidosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy for Mucopolysaccharidosis Revenue
3.4 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio
3.4.1 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Mucopolysaccharidosis Revenue in 2020
3.5 Gene Therapy for Mucopolysaccharidosis Key Players Head office and Area Served
3.6 Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
3.7 Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Type
4.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2022-2027)
5 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Application
5.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy for Mucopolysaccharidosis Market Size (2016-2027)
6.2 North America Gene Therapy for Mucopolysaccharidosis Market Size by Type
6.2.1 North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2027)
6.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Application
6.3.1 North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2027)
6.4 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country
6.4.1 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size (2016-2027)
7.2 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type
7.2.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2027)
7.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application
7.3.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2027)
7.4 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country
7.4.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Type
8.2.1 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Application
8.3.1 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region
8.4.1 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy for Mucopolysaccharidosis Market Size (2016-2027)
9.2 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Type
9.2.1 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Application
9.3.1 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country
9.4.1 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Type
10.2.1 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Application
10.3.1 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country
10.4.1 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sangamo Therapeutics
11.1.1 Sangamo Therapeutics Company Details
11.1.2 Sangamo Therapeutics Business Overview
11.1.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Introduction
11.1.4 Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2016-2021)
11.1.5 Sangamo Therapeutics Recent Development
11.2 Swedish Orphan Biovitrum
11.2.1 Swedish Orphan Biovitrum Company Details
11.2.2 Swedish Orphan Biovitrum Business Overview
11.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Introduction
11.2.4 Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2016-2021)
11.2.5 Swedish Orphan Biovitrum Recent Development
11.3 uniQure
11.3.1 uniQure Company Details
11.3.2 uniQure Business Overview
11.3.3 uniQure Gene Therapy for Mucopolysaccharidosis Introduction
11.3.4 uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2016-2021)
11.3.5 uniQure Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of ICV
Table 4. Key Players of Intracerebral
Table 5. Key Players of Intracisternal
Table 6. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gene Therapy for Mucopolysaccharidosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gene Therapy for Mucopolysaccharidosis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions (2016-2021)
Table 10. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions (2022-2027)
Table 12. Gene Therapy for Mucopolysaccharidosis Market Trends
Table 13. Gene Therapy for Mucopolysaccharidosis Market Drivers
Table 14. Gene Therapy for Mucopolysaccharidosis Market Challenges
Table 15. Gene Therapy for Mucopolysaccharidosis Market Restraints
Table 16. Global Gene Therapy for Mucopolysaccharidosis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players (2016-2021)
Table 18. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2020)
Table 19. Ranking of Global Top Gene Therapy for Mucopolysaccharidosis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
Table 23. Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2016-2021)
Table 27. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Gene Therapy for Mucopolysaccharidosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Application (2016-2021)
Table 31. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sangamo Therapeutics Company Details
Table 64. Sangamo Therapeutics Business Overview
Table 65. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product
Table 66. Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2016-2021) & (US$ Million)
Table 67. Sangamo Therapeutics Recent Development
Table 68. Swedish Orphan Biovitrum Company Details
Table 69. Swedish Orphan Biovitrum Business Overview
Table 70. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product
Table 71. Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2016-2021) & (US$ Million)
Table 72. Swedish Orphan Biovitrum Recent Development
Table 73. uniQure Company Details
Table 74. uniQure Business Overview
Table 75. uniQure Gene Therapy for Mucopolysaccharidosis Product
Table 76. uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2016-2021) & (US$ Million)
Table 77. uniQure Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Mucopolysaccharidosis Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. ICV Features
Figure 4. Intracerebral Features
Figure 5. Intracisternal Features
Figure 6. Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2020 VS 2027
Figure 7. Mucopolysaccharidosis I Case Studies
Figure 8. Mucopolysaccharidosis II Case Studies
Figure 9. Mucopolysaccharidosis III A Case Studies
Figure 10. Mucopolysaccharidosis III B Case Studies
Figure 11. Gene Therapy for Mucopolysaccharidosis Report Years Considered
Figure 12. Global Gene Therapy for Mucopolysaccharidosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Gene Therapy for Mucopolysaccharidosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions: 2020 VS 2027
Figure 15. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions (2022-2027)
Figure 16. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players in 2020
Figure 17. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue in 2020
Figure 19. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2016-2021)
Figure 20. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2022-2027)
Figure 21. North America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Gene Therapy for Mucopolysaccharidosis Market Share by Type (2016-2027)
Figure 23. North America Gene Therapy for Mucopolysaccharidosis Market Share by Application (2016-2027)
Figure 24. North America Gene Therapy for Mucopolysaccharidosis Market Share by Country (2016-2027)
Figure 25. United States Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Type (2016-2027)
Figure 29. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Application (2016-2027)
Figure 30. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Country (2016-2027)
Figure 31. Germany Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Share by Region (2016-2027)
Figure 41. China Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Gene Therapy for Mucopolysaccharidosis Market Share by Type (2016-2027)
Figure 49. Latin America Gene Therapy for Mucopolysaccharidosis Market Share by Application (2016-2027)
Figure 50. Latin America Gene Therapy for Mucopolysaccharidosis Market Share by Country (2016-2027)
Figure 51. Mexico Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Share by Country (2016-2027)
Figure 57. Turkey Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2016-2021)
Figure 61. Swedish Orphan Biovitrum Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2016-2021)
Figure 62. uniQure Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 世界の遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
- 世界の血友病遺伝子治療市場規模・現状・予測（2021年-2027年） Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot an…
- 世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …